(Q38009051)

26 August 2017

Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models (English)

1 reference

26 August 2017

1 reference

Nian Xiong

1

1 reference

26 August 2017

Xi Long

2

1 reference

26 August 2017

Jing Xiong

3

1 reference

26 August 2017

Min Jia

4

1 reference

26 August 2017

Chunnuan Chen

5

1 reference

26 August 2017

Jinsha Huang

6

1 reference

26 August 2017

Devina Ghoorah

7

1 reference

26 August 2017

Xiangquan Kong

8

1 reference

26 August 2017

Zhicheng Lin

9

1 reference

26 August 2017

Tao Wang

10

1 reference

26 August 2017

language of work or name

English

0 references

publication date

11 May 2012

1 reference

Critical Reviews in Toxicology

26 August 2017

1 reference

26 August 2017

42

1 reference

26 August 2017

7

1 reference

26 August 2017

613-632

1 reference

Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism

26 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Mitochondrial complex I inhibition depletes plasma testosterone in the rotenone model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Vascular pathology in male Lewis rats following short-term, low-dose rotenone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Partial mitochondrial inhibition causes striatal dopamine release suppression and medium spiny neuron depolarization via H2O2 elevation, not ATP depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Animal models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

A rat model of Parkinsonism shows depletion of dopamine in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Neurotoxic in vivo models of Parkinson's disease recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

A highly reproducible rotenone model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Early induction of calpains in rotenone-mediated neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Mechanisms of rotenone-induced proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Agmatine effects on mitochondrial membrane potential and NF-κB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Pesticide/environmental exposures and Parkinson's disease in East Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Parkinson-linked genes and toxins that affect neuronal cell death through the Bcl-2 family.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Acute action of rotenone on nigral dopaminergic neurons--involvement of reactive oxygen species and disruption of Ca2+ homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Sleep disturbances in the rotenone animal model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Mitochondrial dysfunction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Sequential and concerted gene expression changes in a chronic in vitro model of parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Involvement of glyceraldehyde-3-phosphate dehydrogenase in rotenone-induced cell apoptosis: relevance to protein misfolding and aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Glyceraldehyde-3-phosphate dehydrogenase: activity inhibition and protein overexpression in rotenone models for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Inhibition by rotenone of mesencephalic neural stem-cell migration in a neurosphere assay in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

MPP+ Analogs Acting on Mitochondria and Inducing Neuro-Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Early environmental origins of neurodegenerative disease in later life

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Synphilin-1 exhibits trophic and protective effects against Rotenone toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Fe(II)‐induced DNA damage in α‐synuclein‐transfected human dopaminergic BE(2)‐M17 neuroblastoma cells: detection by the Comet assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rotenone damages striatal organotypic slice culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Effects of epigallocatechin gallate on rotenone-injured murine brain cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

DJ-1 knock-down in astrocytes impairs astrocyte-mediated neuroprotection against rotenone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rapamycin protects against rotenone-induced apoptosis through autophagy induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

An essay on the shaking palsy. 1817.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Parkinson's disease: insights from non-traditional model organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Environmental risk factors and Parkinson's disease: a metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

C-terminal mechano growth factor protects dopamine neurons: a novel peptide that induces heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Differentiated dopaminergic MN9D cells only partially recapitulate the electrophysiological properties of midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Detoxified extract of Rhus verniciflua stokes inhibits rotenone-induced apoptosis in human dopaminergic cells, SH-SY5Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Diagnosis and treatment of Parkinson disease: molecules to medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Effect of mitochondrial electron transport chain inhibitors on superoxide radical generation in rat hippocampal and striatal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Effects of chronic low dose rotenone treatment on human microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

A neuroprotective role for angiogenin in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rotenone, paraquat, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Increased striatal dopamine turnover following acute administration of rotenone to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Progress in Parkinson's disease-where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Behavioural and neural deficits induced by rotenone in the pond snail Lymnaea stagnalis. A possible model for Parkinson's disease in an invertebrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

The MAP kinase Pmk1 and protein kinase A are required for rotenone resistance in the fission yeast, Schizosaccharomyces pombe

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Investigating convergent actions of genes linked to familial Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rotenone potentiates NMDA currents in substantia nigra dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Rotenone reduces Mg2+-dependent block of NMDA currents in substantia nigra dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Protective effects of asiatic acid on rotenone- or H2O2-induced injury in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Quantitative autoradiographic study on receptor regulation in the basal ganglia in rat model of levodopa-induced motor complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Energy status, ubiquitin proteasomal function, and oxidative stress during chronic and acute complex I inhibition with rotenone in mesencephalic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

DNA polymerase-beta is required for 1-methyl-4-phenylpyridinium-induced apoptotic death in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408444.2012.680431

10.3109/10408444.2012.680431

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference